Paul-Henri Lambert
Direktor/Vorstandsmitglied bei Hookipa Biotech AG
Profil
Paul-Henri Lambert is currently the Director of the International Advanced Vaccinology Course at the University of Geneva.
He also holds the position of Director of the International Advanced Vaccinology Course at Fondation Mérieux.
Additionally, he serves as a Member of the Supervisory Board at Hookipa Biotech AG.
Previously, he worked as the Director at HOOKIPA Pharma, Inc. from 2011 to 2019.
Aktive Positionen von Paul-Henri Lambert
| Unternehmen | Position | Beginn |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | - |
| Fondation Mérieux | Corporate Officer/Principal | 14.11.2013 |
| University of Geneva | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Paul-Henri Lambert
| Unternehmen | Position | Ende |
|---|---|---|
| HOOKIPA PHARMA INC. | Direktor/Vorstandsmitglied | 25.04.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HOOKIPA PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
| Fondation Mérieux | Miscellaneous |
